Brian Lian - Feb 8, 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Feb 8, 2024
Transactions value $
-$6,519,417
Form type
4
Date filed
2/8/2024, 07:40 PM
Previous filing
Jan 31, 2024
Next filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $60.4K +49.1K +2.17% $1.23* 2.31M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.26M -49.1K -2.12% $25.75 2.26M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $651K +140K +6.18% $4.65 2.4M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.56M -60K -2.49% $25.95 2.34M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$2.16M -80K -3.41% $26.95 2.26M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.1M -40K -1.77% $27.45 2.22M Feb 8, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.16M -40K -1.8% $28.90 2.18M Feb 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (right to buy) Options Exercise $0 -14.1K -100% $0.00* 0 Feb 8, 2024 Common Stock 14.1K $1.23 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -34.9K -100% $0.00* 0 Feb 8, 2024 Common Stock 34.9K $1.23 Direct F1
transaction VKTX Stock Option (right to buy) Options Exercise $0 -140K -100% $0.00* 0 Feb 8, 2024 Common Stock 140K $4.65 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023.
F2 25% of the shares subject to the option vested on each one year anniversary of the grant date.